Bulletin
Investor Alert

Akebia Therapeutics Inc.

NAS: AKBA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206920525/composite

$

0.34

Change

+0.02 +7.63%

Volume

Volume 60,076

Sep 23, 2022, 7:56 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206920525/composite

Previous close

$ 0.33

$ 0.32

Change

-0.01 -3.53%

Day low

Day high

$0.30

$0.33

Open
Open: 0.32

52 week low

52 week high

$0.30

$3.35

Open

Market cap

$58.83M

Average volume

2.98M

P/E ratio

N/A

Rev. per Employee

$696,758

EPS

-0.93

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/akba

MarketWatch News on AKBA

  1. Akebia Therapeutics downgraded to neutral from buy at Mizuho

    6:56 a.m. March 31, 2022

    - Tomi Kilgore

  2. Akebia Therapeutics downgraded to underweight from neutral at J.P. Morgan

    8:18 a.m. Jan. 29, 2021

    - Tomi Kilgore

  3. Akebia Therapeutics stock price target cut to $6 from $17 at Mizuho

    6:22 a.m. Sept. 4, 2020

    - Tomi Kilgore

  4. Akebia Therapeutics started at overweight with $12 stock price target at J.P. Morgan

    8:57 a.m. May 2, 2019

    - Tomi Kilgore

  5. Northstar Realty Europe Is a Tough Sell

    8:00 p.m. Sept. 28, 2018

    - Barron's Online

  6. Akebia Therapeutics started at outperform with $18 stock price target at Raymond James

    8:27 a.m. Aug. 14, 2018

    - Tomi Kilgore

  7. Akebia and Keryx say deal will create company with pro forma equity value of about $1.3 bln

    7:05 a.m. June 28, 2018

    - Ciara Linnane

  8. Akebia and Keryx expect deal to close by year-end

    7:06 a.m. June 28, 2018

    - Ciara Linnane

  9. Akebia Therapeutics and Keryx Biopharmaceuticals to merge in all-stock deal

    7:05 a.m. June 28, 2018

    - Ciara Linnane

  10. Akebia shares jump on expanded anemia drug deal with Otsuka

    5:41 p.m. April 25, 2017

    - Wallace Witkowski

  11. Akebia Therapeutics' stock soars 78% to lead Nasdaq gainers after positive trial results

    9:43 a.m. Sept. 9, 2015

    - Tomi Kilgore

  12. Akebia Shares Could More Than Double in a Year

    9:50 a.m. May 18, 2015

    - Barron's Online

  13. 4 stocks to watch

    3:33 p.m. April 16, 2014

    - The Trading Deck

Analyst Ratings

/news/nonmarketwatch/company/us/akba

Other News on AKBA

  1. 10-Q: AKEBIA THERAPEUTICS, INC.

    4:39 p.m. Aug. 4, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Akebia falls as agreement with Otsuka Pharma ends

    7:21 a.m. May 16, 2022

    - Seeking Alpha

  3. Notable earnings after Monday's close

    5:35 p.m. May 8, 2022

    - Seeking Alpha

  4. Akebia Q1 2022 Earnings Preview

    5:35 p.m. May 8, 2022

    - Seeking Alpha

  5. Zoetis (ZTS) Tops Q1 Earnings and Revenue Estimates

    8:25 a.m. May 5, 2022

    - Zacks.com

  6. Akebia falls as FDA rejects kidney disease therapy

    2:34 p.m. March 30, 2022

    - Seeking Alpha

  7. AKBA, TMC and ISIG among mid-day movers

    12:42 p.m. March 30, 2022

    - Seeking Alpha

  8. 10-K: AKEBIA THERAPEUTICS, INC.

    5:34 p.m. March 1, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  9. Loading more headlines...
/news/pressrelease/company/us/akba

Press Releases on AKBA

  1. Akebia Therapeutics to Report Second Quarter Financial Results

    8:00 a.m. July 26, 2022

    - PR Newswire - PRF

  2. Hot Penny Stocks to Buy Now? 3 to Watch in Early July

    5:24 p.m. July 6, 2022

    - Penny Stocks

  3. How to Find Trending Penny Stocks in 2022

    2:00 p.m. July 4, 2022

    - Penny Stocks

  4. Best Penny Stocks To Buy Right Now? 4 To Watch Under $1

    9:03 a.m. July 1, 2022

    - Penny Stocks

  5. What to Know About Trading Penny Stocks on June 13th

    7:00 a.m. June 13, 2022

    - Penny Stocks

  6. Akebia Therapeutics to Present at Jefferies Healthcare Conference

    8:30 a.m. June 3, 2022

    - PR Newswire - PRF

  7. Loading more headlines...

Rates »

Link to MarketWatch's Slice.